Xu Che
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 38
- Pancreatic and Hepatic Oncology Research 31
- Colorectal Cancer Surgical Treatments 3
- Colorectal Cancer Treatments and Studies 3
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 15
- Co-authors
- Chen Hsuan Wu (2 shared papers)Dongxin Lin (2 shared papers)Chengfeng Wang (2 shared papers)Wen Tan (2 shared papers)Dianke Yu (2 shared papers)Liming Huang (1 shared paper)Hui Li (1 shared paper)Tongwen Zhang (1 shared paper)
- Journals
- Frontiers in Oncology (13 papers)HPB (3 papers)World Journal of Gastroenterology (3 papers)BMC Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- ChinaUnited StatesEgypt
In The Last Decade
Xu Che
77 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 77
- Cancer Research 657
- Oncology 500
- Hepatology 149
- Molecular Biology 495
- Genetics 124
Countries citing papers authored by Xu Che
This map shows the geographic impact of Xu Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Che more than expected).
Fields of papers citing papers by Xu Che
This network shows the impact of papers produced by Xu Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Che. The network helps show where Xu Che may publish in the future.
Co-authors
The 25 scholars most cited alongside Xu Che, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 496 | |
| 2 | 2019 | 320 | |
| 3 | 2016 | 235 | |
| 4 | 2011 | 170 | |
| 5 | 2014 | 90 | |
| 6 | 2021 | 76 | |
| 7 | 2019 | 63 | |
| 8 | 2021 | 55 | |
| 9 | 2019 | 43 | |
| 10 | 2017 | 38 | |
| 11 | 2011 | 35 | |
| 12 | 2021 | 33 | |
| 13 | 2017 | 30 | |
| 14 | 2021 | 25 | |
| 15 | 2014 | 22 | |
| 16 | 2020 | 22 | |
| 17 | 2018 | 21 | |
| 18 | 2017 | 18 | |
| 19 | 2016 | 16 | |
| 20 | 2023 | 15 |
About Xu Che
Xu Che is a scholar working on Oncology, Hepatology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 83 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (31 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer-related molecular mechanisms research (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Gallbladder and Bile Duct Disorders (3 papers). The work is most often cited by research in Cancer Research (657 citations), Oncology (500 citations), Hepatology (149 citations), Molecular Biology (495 citations) and Genetics (124 citations). Xu Che has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include Chen Hsuan Wu, Dongxin Lin, Chengfeng Wang, Wen Tan, Dianke Yu, Liming Huang, Hui Li, Tongwen Zhang, Jian Xu and Lei Zheng. Their work appears in journals such as Frontiers in Oncology, HPB, World Journal of Gastroenterology, BMC Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.